Pharma companies are constantly challenged to build pipelines with innovative drugs that have high potential for approval and reimbursement. In order to build an effective portfolio, it is essential to choose the most valuable projects, prioritize appropriately and then plan resources for implementation. To add to this, drug discovery and development is a tremendously competitive field. In an increasing number of countries, a company must be first or best in class to gain market access. Generating “me too” compounds is no longer a strategic option for companies.
Competitive intelligence (CI) has historically been used as a means to evaluate the landscape and leverage it for decision making. Now, more than ever, it is critical to continually evaluate the CI function within companies to ensure it is delivering actionable insights to help executives make the right decisions.
During this webinar we will provide an insight into current Pharma CI practice, trends and best practice and discuss topics like
- State of the nation: feedback/benchmarks on pharmaceutical CI
- Current practice: typical CI offerings and challenges
- Best practice
- Future outlook
Jamie Munro, Global Practice Leader, Portfolio and Licensing, Clarivate Analytics
Jamie joined Clarivate from AstraZeneca where he was Head of Portfolio Analytics and Insights and spent eight years in increasingly more senior roles. As well as heading the Portfolio & Licensing practice, Jamie heads CMR International, the R&D benchmarking company.
With more than 15 years in the life sciences, Jamie has extensive experience in the areas of portfolio management, analytics, benchmarking and more recently working with investor relations on communications and messaging regarding promoting the AZ drug pipeline and portfolio.
Earlier experience includes a decade spent in technology consultancy involving portfolio management systems, web technologies, data mining and reporting. Jamie holds a PhD in finance and gained his tenure in academia before leaving to pursue a career in industry.
Karthik Subramanian Senior Product Strategy Manager, Clarivate Analytics
Karthik leads the Product Management and Strategy for Cortellis Competitive Intelligence Products at Clarivate Analytics. Karthik works closely with customers in the pharmaceutical space, formulating strategies and providing products and solutions to help meet their needs. Karthik has extensive experience in the areas of product management, program management and consulting, having worked for more than 12 years in the life sciences industry. Karthik holds an MBA in Strategy from the University of Leeds, in the UK.
Who Should Attend?
- President , CEO, CFO, COO, CSO
- VP/Director of Strategy and Portfolio
- VP/Director Portfolio & Licensing
- VP/Director Business Development
- VP/Director of Market / Competitive Intelligence
- VP/Director of Global Commercial Operations
Clarivate™ Analytics accelerates the pace of innovation by providing trusted insights and analytics to customers around the world, enabling them to discover, protect and commercialize new ideas faster. Formerly the Intellectual Property and Science business of Thomson Reuters, we own and operate a collection of leading subscription-based businesses focused on scientific and academic research, patent analytics and regulatory standards, pharmaceutical and biotech intelligence, trademark protection, domain brand protection and intellectual property management. Clarivate™ Analytics is now an independent company with over 4,000 employees, operating in more than 100 countries and owns well-known brands that include Web of Science™, Cortellis™, Thomson Innovation™, Derwent World Patents Index™, CompuMark™, MarkMonitor® and Techstreet™, among others. For more information, please visit clarivate.com.